Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy
Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy
Recruiting · NCT05518578 · Registry updated 2026-04-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy | Epileptic Seizures, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system disorder, epilepsy, nervous system disorder, visual epilepsy | Recruiting | Phase 2 | 2026-04-21 | NCT05518578 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Supernus Pharmaceuticals, Inc. | 9 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Box Hill Hospital | Box Hill | Australia | 43 |
| Green Leaf Clinical Trials, LLC | Jacksonville | United States | 1 |
| Prince of Wales Hospital | Randwick | Australia | 34 |
| Royal Brisbane and Women's Hospital | Brisbane | Australia | 5 |
| Royal Prince Alfred Hospital | Sydney | Australia | 19 |
| The Alfred Hospital | Melbourne | Australia | 110 |
| The Austin Hospital | Heidelberg | Australia | 3 |
| The Royal Melbourne Hospital | Parkville | Australia | 26 |
| Visionary Investigators Network | Miami | United States | 9 |
| Westmead Hospital | Sydney | Australia | 32 |